Drug Type Oligonucleotide |
Synonyms- |
Target |
Action inhibitors |
Mechanism CEBPA inhibitors(CCAAT enhancer binding protein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hepatocellular Carcinoma | Discovery | - | 02 Dec 2025 |





